Cherry Creek Investment Advisors’s NovoCure NVCR Stock Holding History

Cherry Creek Investment Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,890	Closed	-$234K	–	97
2023 Q1	$234K	Sell	3,890 -2,770	-42%	-$221K	0.17%	75
2022 Q4	$489K	Hold	6,660	–	–	0.38%	51
2022 Q3	$506K	Buy	6,660 +200	+3%	+$15.6K	0.42%	50
2022 Q2	$449K	Buy	6,460 +150	+2%	+$11.3K	0.36%	53
2022 Q1	$523K	Buy	6,310 +555	+10%	+$40.9K	0.34%	57
2021 Q4	$432K	Hold	5,755	–	–	0.27%	59
2021 Q3	$669K	Sell	5,755 -200	-3%	-$30.2K	0.45%	48
2021 Q2	$1.32M	Buy	+5,955	New	+$1.16M	0.87%	38

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Cherry Creek Investment Advisors's NVCR Position: Q2 2023 in Review

Cherry Creek Investment Advisors sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 3,890 shares — an estimated $234K sold.

Cherry Creek Investment Advisors first reported a position in NVCR in Q2 2021 and held it in 8 quarters. The position peaked at $1.32M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

Cherry Creek Investment Advisors reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
Cherry Creek Investment Advisors sold 3,890 NovoCure shares in Q2 2023, an estimated $234K.
Cherry Creek Investment Advisors first reported a position in NovoCure in Q2 2021 and held it in 8 quarters.
Cherry Creek Investment Advisors's NovoCure position peaked at $1.32M in Q2 2021.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2023, filed 14 Jul 2023.